Skip to main content
Log in

[18F]-NaF PET/CT imaging in cardiac amyloidosis

  • Images that Teach
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Cardiac amyloidosis (CA) is recognized as a common cause of restrictive cardiomyopathy and heart failure due to the deposition of insoluble proteins in the myocardial interstitium. We emphasize the role of [18F]-sodium fluoride (NaF) PET/CT as a potential noninvasive tool to identify and differentiate the transthyretin-related cardiac amyloidosis from the light-chain cardiac amyloidosis. We report cases of a 73-year-old man and a 75-year-old woman followed in our center for congestive heart failure with marked alteration of the left ventricular ejection fraction due to familial transthyretin Val122Ile cardiac amyloidosis and light-chain cardiac amyloidosis, respectively, confirmed on endomyocardial biopsy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Galat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D, et al. Uselfulness of 99mTc HMDP-scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Amyloid. 2015 (in press).

  2. Glaudemans AWJM, van Rheenen RWJ, van den Berg MP, Noordzij W, Koole M, Blokzijl H, et al. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis. Amyloid. 2014;21:35–44.

    Article  CAS  PubMed  Google Scholar 

  3. Worsley DF, Lentle BC. Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals. J Nucl Med. 1993;34:1612–5.

    CAS  PubMed  Google Scholar 

  4. Kulhanek J, Movahed A. Uptake of technetium 99m HDP in cardiac amyloidosis. Int J Cardiovasc Imaging. 2003;19:225–7.

    Article  PubMed  Google Scholar 

  5. Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, et al. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. JACC Cardiovasc Imaging. 2011;4:659–70.

    Article  PubMed  Google Scholar 

Download references

Disclosure

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Axel Van Der Gucht MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Van Der Gucht, A., Galat, A., Rosso, J. et al. [18F]-NaF PET/CT imaging in cardiac amyloidosis. J. Nucl. Cardiol. 23, 846–849 (2016). https://doi.org/10.1007/s12350-015-0287-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-015-0287-0

Keywords

Navigation